StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Impact of Acquisitions — Specialty Diagnostics by Quarter

Impact of Acquisitions — Specialty Diagnostics (%)

QuarterlyAnnual

Thermo Fisher Scientific Impact of Acquisitions — Specialty Diagnostics: -6.0% in Q3 2026, down 6.0 pts from a year earlier. That is the lowest of the 15 quarters on record here.

Latest, Q3 2026
-6.0%
Period ended Sep 30, 2026
Change on a year earlier
-6.0 pts
0.0% in Q3 2025
History
15 quarters
Since Q1 2023
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“SD: Impact of acquisitions/divestitures 0% 0% 0% 0% 0% 0% 0% -6%”

Source: Q3 2026 Reconciliation of Financial Information ↗

Reported in IR Financial Reconciliation Package & SEC MD&A.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedImpact of Acquisitions — Specialty Diagnostics (%)Year on yearSource
Q3 2026Sep 30, 2026-6.0%-6.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20260.0%0.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 20260.0%0.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20250.0%0.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 20250.0%0.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 20250.0%0.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 20250.0%0.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 20240.0%-6.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 20240.0%-6.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 20240.0%-6.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 20240.0%-4.0 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 20236.0%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 20236.0%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 20236.0%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 20234.0%–Q4 & FY2024 Reconciliation of Financial Information ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Impact of Acquisitions — Specialty Diagnostics (%), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/org-acq-pct-sd

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.